James Wilson's GEMMABio Secures $34 Million to Advance Gene Therapy
Philadelphia-based GEMMA Biotherapeutics (GEMMABio), a newly established therapeutics company led by gene therapy pioneer Dr. Jim Wilson, has announced the …
News
Irish AI Startup Focused on Natural Peptide Discovery Secures $42M
Nuritas, an Irish biotech company specializing in AI-powered peptide discovery from natural sources, announced it has raised $42 million in …
Alphabet's AI Spinoff Raises $300M at $5.3B Valuation Amid Biopharma Partnerships
SandboxAQ, a Palo Alto SaaS startup, operating at the intersection of artificial intelligence and quantum technology, announced it has raised …
BioAge Labs and Novartis Ink $500M Deal to Tackle Aging-Related Diseases
BioAge Labs, a clinical-stage biopharmaceutical company developing therapies targeting the biology of aging, announced a multi-year collaboration with Novartis worth …
After Raising $13M, AI-Driven Protein Biotech Appoints Board Chair
ExpressionEdits, a biotechnology company leveraging AI and proprietary intronization technology to optimize protein expression, announced the appointment of Dr. Paul …
Noetik Announces Foundation Models of Spatial Biology for Precision Oncology
After securing $40 million in August 2024, Noetik—an AI-native biotechnology company—announced in a recently released technical report the launch of …
Bristol Myers Squibb Grants $25M for insitro’s Milestone in ALS Target Discovery
insitro has secured $25 million in milestone payments from Bristol Myers Squibb for reaching discovery milestones and identifying the first …
Sanofi Opens Call for Proposals for 2025 iNext Awards North America
Sanofi has opened pre-proposal submissions for its 2025 iNext Awards, a pioneering program aimed at advancing high-risk, high-reward innovations in …
Gameto Achieves First Live Birth Using Egg Maturation Technology Outside the Body
Gameto, a biotechnology company focused on fertility treatments, announced the world’s first live birth using Fertilo, its ovarian support cell …
Gilead Sciences and Terray Therapeutics Partner to Advance AI-Driven Small Molecule Drug Discovery
Just two months after raising $120 million to advance its AI-driven tNova platform and internal immunology programs, Terray Therapeutics has …
Researchers Discover Role of tRNA Fragments in Cancer Progression
A recent study by researchers at Chung-Ang University, South Korea, published in Nature Communications, reveals how a specific transfer RNA-derived …
Candid and EpimAb Collaborate to Develop T-Cell Engagers for Autoimmune Diseases
After debuting with 370$ million capital raise in September 2024, Candid Therapeutics, a San Diego-based biotechnology company specializing in T-cell …